BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8851611)

  • 1. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Bryson HM; Brogden RN
    Drugs; 1993 Apr; 45(4):589-621. PubMed ID: 7684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
    Blouin RA; Kneer J; Ambros RJ; Stoeckel K
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
    Cornaglia G; Ligozzi M; Bauernfeind A; Satta G; Fontana R
    New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
    Koup JR; Dubach UC; Brandt R; Wyss R; Stoeckel K
    Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
    Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
    Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
    Blouin RA; Kneer J; Stoeckel K
    Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.
    Stoeckel K; Tam YK; Kneer J
    Curr Med Res Opin; 1989; 11(7):432-41. PubMed ID: 2673663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of oral cefuroxime axetil into the human aqueous humor.
    Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
    Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature survey on clinical efficacy and tolerability on cefetamet pivoxil: an analysis of 3,128 cases.
    Kissling M; Chadbourne U
    Respiration; 1993; 60 Suppl 1():45-54. PubMed ID: 8480090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefetamet in plasma and skin blister fluid.
    Zimmerli W; Sansano S; Wittke B
    Antimicrob Agents Chemother; 1996 Jan; 40(1):102-4. PubMed ID: 8787888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL; Kneer J; Blouin RA; Stoeckel K
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefetamet pivoxil in community-acquired pneumonia: an overview.
    Kissling M
    Curr Med Res Opin; 1992; 12(10):631-9. PubMed ID: 1633721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.
    Tam YK; Kneer J; Dubach UC; Stoeckel K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):957-9. PubMed ID: 2764545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children.
    Hayton WL; Walstad RA; Thurmann-Nielsen E; Kufaas T; Kneer J; Ambros RJ; Rugstad HE; Monn E; Bodd E; Stoeckel K
    Antimicrob Agents Chemother; 1991 Apr; 35(4):720-5. PubMed ID: 2069377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of cefuroxime into chronically inflamed sinus mucosa.
    Dinis PB; Monteiro MC; Lobato R; Martins ML; Gomes A
    Laryngoscope; 1999 Nov; 109(11):1841-7. PubMed ID: 10569419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection.
    Grassi GG
    Drugs; 1994; 47 Suppl 3():35-42. PubMed ID: 7518765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability.
    Stoeckel K; Hofheinz W; Laneury JP; Duchene P; Shedlofsky S; Blouin RA
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2602-6. PubMed ID: 9756762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.